MANAGEMENT OF CASTRATION-RESISTANT PROSTATE CANCER: A CALL TO UROLOGISTS

被引：4

作者：

Fitzpatrick, John M. ^{[1
]}

机构：

[1] Univ Coll Dublin, Mater Misericordiae Hosp, Dublin 7, Ireland

来源：

BJU INTERNATIONAL | 2012年 / 110卷 / 06期

关键词：

MITOXANTRONE PLUS PREDNISONE; ANDROGEN RECEPTOR; BREAST-CANCER; OPEN-LABEL; DOCETAXEL; CHEMOTHERAPY;

D O I：

10.1111/j.1464-410X.2012.11332.x

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：772 / 774

页数：3

共 25 条

[1] Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial [J].

Albain, Kathy S. ;

Barlow, William E. ;

Ravdin, Peter M. ;

Farrar, William B. ;

Burton, Gary V. ;

Ketchel, Steven J. ;

Cobau, Charles D. ;

Levine, Ellis G. ;

Ingle, James N. ;

Pritchard, Kathleen I. ;

Lichter, Allen S. ;

Schneider, Daniel J. ;

Abeloff, Martin D. ;

Henderson, I. Craig ;

Muss, Hyman B. ;

Green, Stephanie J. ;

Lew, Danika ;

Livingston, Robert B. ;

Martino, Silvana ;

Osborne, C. Kent .

LANCET, 2009, 374 (9707) :2055-2063

[2]

[Anonymous], J CLIN ONCOL S5

[3] New Strategies in Metastatic Prostate Cancer: Targeting the Androgen Receptor Signaling Pathway [J].

Attard, Gerhardt ;

Richards, Juliet ;

de Bono, Johann S. .

CLINICAL CANCER RESEARCH, 2011, 17 (07) :1649-1657

[4]

Charles B, 2012, HUGGINS NOBEL LECT

[5] Abiraterone and Increased Survival in Metastatic Prostate Cancer [J].

De Bono, Johann S. ;

Logothetis, Christopher J. ;

Molina, Arturo ;

Fizazi, Karim ;

North, Scott ;

Chu, Luis ;

Chi, Kim N. ;

Jones, Robert J. ;

Goodman, Oscar B., Jr. ;

Saad, Fred ;

Staffurth, John N. ;

Mainwaring, Paul ;

Harland, Stephen ;

Flaig, Thomas W. ;

Hutson, Thomas E. ;

Cheng, Tina ;

Patterson, Helen ;

Hainsworth, John D. ;

Ryan, Charles J. ;

Sternberg, Cora N. ;

Ellard, Susan L. ;

Flechon, Aude ;

Saleh, Mansoor ;

Scholz, Mark ;

Efstathiou, Eleni ;

Zivi, Andrea ;

Bianchini, Diletta ;

Loriot, Yohann ;

Chieffo, Nicole ;

Thian Kheoh ;

Haqq, Christopher M. ;

Scher, Howard I. .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (21) :1995-2005

[6] Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial [J].

de Bono, Johann Sebastian ;

Oudard, Stephane ;

Ozguroglu, Mustafa ;

Hansen, Steinbjorn ;

Machiels, Jean-Pascal ;

Kocak, Ivo ;

Gravis, Gwenaelle ;

Bodrogi, Istvan ;

Mackenzie, Mary J. ;

Shen, Liji ;

Roessner, Martin ;

Gupta, Sunil ;

Sartor, A. Oliver .

LANCET, 2010, 376 (9747) :1147-1154

[7] Bilateral orchiectomy with or without flutamide for metastatic prostate cancer [J].

Eisenberger, MA ;

Blumenstein, BA ;

Crawford, ED ;

Miller, G ;

McLeod, DG ;

Loehrer, PJ ;

Wilding, G ;

Sears, K ;

Culkin, DJ ;

Thompson, IM ;

Bueschen, AJ ;

Lowe, BA .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (15) :1036-1042

[8] Inhibition of the Androgen Receptor as a Novel Mechanism of Taxol Chemotherapy in Prostate Cancer [J].

Gan, Lu ;

Chen, Shuai ;

Wang, Yuwei ;

Watahiki, Akira ;

Bohrer, Laura ;

Sun, Zhen ;

Wang, Yuzhuo ;

Huang, Haojie .

CANCER RESEARCH, 2009, 69 (21) :8386-8394

[9] Prostate cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up [J].

Horwich, A. ;

Parker, C. ;

Kataja, V. .

ANNALS OF ONCOLOGY, 2009, 20 :76-78

[10]

Huggins C, 1941, CANCER RES, V1, P293

← 1 2 3 →